Foresite Capital Management V, LLC
WEST HOLLYWOOD, CA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$289.1M2026 Q3
Positions9
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%
What Changed This Quarter?
Top Holdings
CGON
CG Oncology
26.5%
LTGO
Latigo Biotherapeutics
20.6%
ALMS
Alumis
15.1%
HIMS
Hims & Hers
9.1%
IRON
Disc Medicine
8.5%
PHVS
Pharvaris N.V.
7.3%
ODTX
Odyssey Therapeutics
5.6%
NRIX
Nurix Therapeutics
3.8%
New / Increased
1 new · 3 increased
LTGONEW
Latigo Biotherapeutics
20.6%
NRIX
Nurix Therapeutics
3.8%
+73.1%
HIMS
Hims & Hers
9.1%
+19.7%
ODTX
Odyssey Therapeutics
5.6%
+2.3%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.